创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Development of New Drugs Targeting Cancer Metabolism: Challenges and Opportunities
HUANG Min
2024, 48(12): 881-886. DOI: 10.20053/j.issn1001-5094.2024.12.001
Abstract PDF
Research Progress of Small Molecule Drugs Targeting Tumor Metabolic Enzymes
LI Shunyao, FENG Lei, ZHANG Xinchen, HUANG Yiyang, YAO Xueying, ZHOU Lu
2024, 48(12): 887-907. DOI: 10.20053/j.issn1001-5094.2024.12.002
Abstract PDF
Small-Molecule Inhibitors Targeting Metabolic Enzymes of the Oxidative Pentose Phosphate Pathway
SUN Huanran, ZHANG Qijun, SHAN Changliang
2024, 48(12): 908-916. DOI: 10.20053/j.issn1001-5094.2024.12.003
Abstract PDF
Advances in the Application of Metabolomics in Identification of Biomarkers for Immunotherapy Efficacy
ZHANG Haoyue, HU Zeping
2024, 48(12): 917-928. DOI: 10.20053/j.issn1001-5094.2024.12.004
Abstract PDF
Research Progress of Histamine H4 Receptor and Its Antagonists
TANG Hongming, HOU Tao, WANG Jixia, ZHOU Weijia
2024, 48(12): 929-941. DOI: 10.20053/j.issn1001-5094.2024.12.005
Abstract PDF
Role of Vitamin D- Vitamin D Receptor Axis in Chronic Kidney Disease
SUN Juan, CUI Xueyang, WANG Hefei, JIANG Zhenzhou, HUANG Xin
2024, 48(12): 942-950. DOI: 10.20053/j.issn1001-5094.2024.12.006
Abstract PDF
Clinical Application and Research Progress of Anticancer Peptides
SUN Xin, LIU Yanchao, ZHENG Heng
2024, 48(12): 951-960. DOI: 10.20053/j.issn1001-5094.2024.12.007
Abstract PDF